DSIP
DSIP is a small neuropeptide studied for sleep architecture, stress physiology, and neuroendocrine regulation.
What DSIP is
DSIP, or delta sleep-inducing peptide, was first described in sleep-related peptide research and remains scientifically interesting partly because its biology is unresolved. Older human and animal studies examined sleep latency, slow-wave sleep, withdrawal-related states, and neuroendocrine effects. Later reviews emphasize that DSIP is a complicated signal with inconsistent findings across models.
Modern education should avoid portraying DSIP as a simple sleep drug. Research-grade DSIP is Research Use Only and is not an approved drug product. Reported exposure values come from older experimental literature and animal work, so species, route, and assay method are essential context.
How it works
DSIP has been investigated as a neuromodulatory peptide associated with sleep regulation, stress responses, and endocrine signaling. Its exact receptor pharmacology remains unclear, and published reviews describe it as an unresolved molecule rather than a clean single-target agonist. Research readouts include sleep-stage architecture, sleep latency, EEG delta activity, and neurochemical stress markers. Variable degradation, distribution, and assay limitations complicate interpretation.
Who works with it, and what they are measuring
DSIP is studied by sleep researchers, neuroendocrinologists, peptide biochemists, and historical pharmacology groups. Because much of the literature is older, careful reviewers pay close attention to methods, species, and measurement technology.
What the research examines
Research areas, not results. A topic on this list is being studied, not settled.
How it appears in the literature
Taken from the methods sections of the cited work. Not a recommendation.
| Research context | Reported amount | Frequency | Route |
|---|---|---|---|
| Human sleep studies reported DSIP exposure in nmol/kg ranges, converted approximately to mcg/kg | 20 mcg – 40 mcg | single study administration | intravenous |
| Cat sleep EEG study using subcutaneous DSIP | 102 mcg | single pre-recording administration | subcutaneous |
Handling & storage
Lyophilized DSIP is commonly stored cold, dry, and protected from light; reconstituted research solutions are usually refrigerated and used promptly.
Notes on combined research
DSIP is often discussed with sleep or stress-axis compounds, but its own mechanism is not fully resolved. Combining it with sedatives, GABAergic research compounds, or circadian interventions can make sleep-stage findings hard to interpret and should be handled as controlled research only.
DSIP questions
Older DSIP studies report experimental exposures by route and sometimes by nmol/kg. These are literature values only, not human-use instructions.
Research vials are commonly modeled with 1-2 mL reconstitution volumes. The correct lab concentration depends on the assay plan.
DSIP is not supported by a standard daily dosage in modern clinical guidance. Published protocols should be read individually.
A DSIP chart should show species, route, original units, and converted units. Older nmol/kg data should not be flattened into a supplement-style chart.
Sleep studies measure effects during the recording night or short observation windows. Longer-term timing claims are much less settled.
A reliable practical half-life is not well established. Researchers focus on EEG and sleep-stage outcomes more than a simple half-life number.
It can be studied with other sleep variables, but stacking can obscure EEG interpretation. Research-grade DSIP is not for human consumption.
Read the research yourself
These references were validated against the NCBI database. No citation appears here unless it resolves to a real paper.